Efficacy and Safety of an Antiviral Polymeric Nasal Spray: A Randomized, Parallel Group, Double-blind, Placebo-controlled Study in Subjects With Early Symptoms of Common Cold.
Phase of Trial: Phase II
Latest Information Update: 08 May 2012
At a glance
- Drugs RC 591 (Primary)
- Indications Common cold
- Focus Therapeutic Use
- 08 May 2012 Actual patient number 163 added as reported by ClinicalTrials.gov.
- 08 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Apr 2012 Planned End Date changed from 1 Apr 2012 to 1 May 2012 as reported by ClinicalTrials.gov.